Ionpath vs RareCyte, Inc.
Ionpath
Enabling precision medicine through high-definition spatial proteomics
32 employees · est. 2014 · Menlo Park, United States
RareCyte, Inc.
A one-stop resource for Spatial Biology and Liquid Biopsy solutions
65 employees · est. 2009 · Seattle, United States
RareCyte, Inc. is the older company (2014 vs 2009); RareCyte, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Ionpath | RareCyte, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2009 older |
| Headquarters | ||
| Headquarters | Menlo Park, United States | Seattle, United States |
| Employees | ||
| Employees | 32 | 65 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Corporate Round | Venture round |
| Total Funding | ||
| Total Funding | $18.00M | $96.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 6 |
| Taxonomy | ||
| Taxonomy | Medical ImagingIon Beam TechnologyCancer DiagnosisTissue AnalysisBiopsy TechnologyPrecision Medicine +1 | Spatial BiologyLiquid BiopsyRareCytePrecision BiologyOncologyImmuno-oncology +9 |
| Website | ||
| Website | ionpath.com | rarecyte.com |
About Ionpath
Ionpath has developed advanced ion beam imaging technology to revolutionize cancer diagnosis, with the aim of contributing to the improvement of human health. This innovation enables the precise examination of tissue biopsies, surpassing the capabilities of light microscopy. By catering to various t...
About RareCyte, Inc.
RareCyte, Inc. is a prominent player in the field of Spatial Biology and Liquid Biopsy solutions, offering a comprehensive range of services to leaders across Research, Translational Medicine, and the Clinic. Headquartered in Seattle, WA, the company has been at the forefront of developing innovativ...
Also comparing in this category
Comparing more than these two?
Get Ionpath, RareCyte, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Ionpath compare?
A PDF of Ionpath and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Ionpath with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Ionpath on 12 Sep 2024, and RareCyte, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
